stockrow
Saturday 7 November 2026
Export SCNX’s income statement to Excel — free account
Scienture Holdings, Inc.
SCNX Healthcare Pharmaceutical Retailers
Scienture Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $431,600.00, up 216.0% from fiscal 2024.
- Revenue
- +3,235.9%
- EPS
- +85.4%
- Free cash flow
- −54.0%
- Total debt
- +831.4%
Quarter to June 2026, against a year earlier
3.13
0.03
+0.97%
Follow SCNX
Alert me
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
3 | 5 | 5 | 4 | 4 | 2 | 4 | 2 | 4 | 5 |
P/E ratio |
0.00 | 49.79 | 1,071.43 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.25 | 0.00 |
P/S ratio |
5.84 | 4.91 | 2.52 | 5.26 | 2.39 | 1.94 | 0.24 | 3.00 | 82.20 | 16.15 |
Altman Z-Score |
(35.62) | (2.11) | 1.01 | 16.40 | 22.39 | 1.23 | (6.68) | (5.41) | (0.53) | (2.60) |
Altman Z″-Score (non-manufacturers) |
(124.35) | (38.05) | (9.71) | 2.14 | 8.44 | (9.45) | (22.60) | (15.57) | 0.96 | (0.88) |
P/FCF ratio |
0.00 | 83.74 | 35.31 | 878.70 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
(63.89) | 269.75 | 229.28 | (213.91) | (57.11) | (45.00) | 2.10 | (4.02) | (7.02) | (1.51) |
Beneish M-Score |
(13.36) | (1.24) | (2.47) | (1.72) | (1.19) | (4.34) | (3.87) | 14.21 | 19.51 | (3.19) |
P/B ratio |
0.00 | 0.00 | 11.43 | 9.44 | 4.71 | 5.09 | 7.29 | 7.55 | 0.26 | 0.11 |
Price to Tangible BV |
0.00 | 0.00 | 81.32 | 11.45 | 5.14 | 6.31 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
5.86 | 5.00 | 2.44 | 4.91 | 2.08 | 1.75 | 0.21 | 3.17 | 85.10 | 6.75 |
EV/EBITDA |
0.00 | 30.30 | 0.00 | 166.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(28.90) | 85.38 | 34.27 | 257.71 | (16.06) | (6.75) | (1.34) | (1.95) | (1.48) | (0.24) |
EV/FCF |
(28.90) | 85.38 | 34.27 | 821.19 | (15.79) | (6.66) | (1.34) | (2.06) | (1.26) | (0.21) |
Quick Ratio |
0.21 | 0.96 | 1.51 | 7.03 | 9.28 | 4.43 | 0.80 | 0.11 | 0.56 | 2.70 |
Current Ratio |
0.23 | 1.16 | 1.70 | 7.30 | 10.95 | 4.72 | 0.98 | 0.24 | 0.80 | 2.89 |
Net Debt/EBITDA |
(0.86) | 1.00 | 0.29 | (11.63) | 2.20 | 0.36 | 0.15 | (0.01) | (0.05) | 0.17 |
Debt/Assets |
231.80% | 107.92% | 37.89% | 5.61% | 6.41% | 21.65% | 18.78% | 0.20% | 0.98% | 0.00% |
Debt/Equity |
(0.68) | (2.14) | 1.00 | 0.08 | 0.07 | 0.33 | 2.03 | 0.05 | 0.01 | 0.00 |
Asset Turnover |
2.10 | 6.14 | 2.69 | 1.91 | 2.23 | 1.27 | 2.16 | 0.17 | 0.00 | 0.00 |
Operating CF/Net income |
0.18 | 0.59 | 30.38 | (0.50) | 0.87 | 0.48 | 0.45 | 0.12 | (1.57) | 0.32 |
Capex/Depreciation |
0.00 | 0.00 | (75.00) | (0.87) | (0.37) | (0.16) | 0.00 | 0.00 | (0.01) | 0.00 |
Interest Coverage |
(6.65) | 2.52 | (1.52) | 2.35 | (85.26) | (224.25) | (8.67) | (3.85) | (11.01) | (10.43) |
| 626.51% | (39.59%) | 3.38% | (11.41%) | (39.57%) | (85.40%) | (168.83%) | (4,031.09%) | 22.77% | (55.65%) | |
| (233.43%) | 60.55% | 0.63% | (7.29%) | (33.01%) | (68.33%) | (73.28%) | (219.71%) | 15.45% | (43.92%) | |
ROIC |
0.00% | 144.75% | (6.68%) | 4.95% | (46.25%) | (174.44%) | 0.00% | (484.54%) | (11.52%) | (41.95%) |
Return on Tangible Assets |
242.65% | 352.01% | 1.45% | (8.23%) | (29.69%) | (149.87%) | (30,192.17%) | 202.87% | (572.37%) | (798.85%) |
Average Days of Receivables |
43.99 | 39.78 | 41.30 | 38.88 | 40.35 | 36.13 | 22.43 | 327.77 | 11,088.68 | 618.45 |
Research and Development Expense of Revenue |
11.56% | 12.80% | 24.79% | 8.70% | 3.87% | 0.00% | 0.00% | 0.00% | 1,637.41% | 453.27% |
Selling, General and Administrative Expense of Revenue |
140.58% | 86.52% | 90.57% | 58.86% | 43.73% | 58.07% | 51.42% | 143.95% | 6,433.82% | 2,327.29% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.33 | 0.13 | 0.00 | 0.00 | 0.12 | 0.72 | 0.93 | 0.84 |
Share Based Compensation of Revenue |
5.95% | 9.56% | 4.43% | 3.79% | 10.88% | 3.94% | 3.25% | 21.08% | 3,384.99% | 1,477.99% |
Graham Net Nets |
(0.08) | (0.02) | 0.01 | 0.06 | 0.20 | 0.12 | (0.51) | (2.26) | (0.95) | (0.78) |
Graham Number |
624.40 | 0.00 | 28.94 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 942.04 | 0.00 |
Earnings Yield |
(20.42%) | 2.01% | 0.09% | (0.73%) | (6.06%) | (27.53%) | (138.92%) | (437.24%) | 44.52% | (541.18%) |
Free Cash Flow Yield |
(3.47%) | 1.19% | 2.83% | 0.11% | (5.51%) | (13.55%) | (62.56%) | (51.46%) | (82.42%) | (203.69%) |
Revenue per Share |
177.28 | 206.43 | 267.96 | 470.65 | 831.19 | 455.73 | 453.55 | 44.57 | 1.01 | 0.70 |
Operating CF per Share |
(35.96) | 12.09 | 19.12 | 8.97 | (107.51) | (118.26) | (69.23) | (72.72) | (105.67) | (21.79) |
Capex per Share |
0.00 | 0.00 | (1.05) | (5.21) | (1.82) | (1.04) | 0.03 | 0.00 | (0.09) | 0.00 |
Free Cash Flow per Share |
(35.96) | 12.09 | 18.07 | 3.77 | (109.33) | (119.30) | (69.20) | (72.72) | (105.76) | (21.79) |
Cash per Share |
1.05 | 12.95 | 60.81 | 181.75 | 287.36 | 143.90 | 48.45 | 0.01 | 2.28 | 10.85 |
Shareholders Equity per Share |
(82.01) | (21.96) | 59.07 | 262.04 | 421.32 | 173.74 | 15.17 | 17.73 | 585.72 | 114.22 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(82.01) | (21.96) | 59.07 | 262.04 | 421.32 | 173.74 | 15.17 | 17.73 | 585.72 | 114.22 |
Free Cash Flow |
(0.50) | 0.17 | 0.26 | 0.06 | (2.25) | (2.59) | (1.56) | (2.23) | (14.28) | (13.38) |
Working Capital |
(1.14) | 0.08 | 0.61 | 3.28 | 8.38 | 3.45 | (0.05) | (8.80) | (1.60) | 5.18 |
Capital Expenditures |
— | — | (0.01) | (0.08) | (0.04) | (0.02) | 0.00 | — | (0.01) | — |
Net Current Asset Value |
(1.15) | (0.32) | 0.08 | 2.37 | 8.11 | 2.38 | (1.27) | (9.24) | (19.48) | (6.14) |
EV/EBIT |
0.00 | 37.11 | 0.00 | 291.64 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.09 | 0.00 |
Price to Operating Income |
0.00 | 36.39 | 0.00 | 312.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.00 | 0.00 | 0.01 | 0.54 | 0.63 | 1.41 | 2.99 | 139.97 | 55.19 | 235.67 |
Cash ROIC |
143.04% | 31.89% | 10.10% | 0.81% | (14.79%) | (31.80%) | (73.27%) | (391.97%) | (17.76%) | (17.43%) |
Accounts Receivable Turnover |
7.59 | 9.48 | 10.18 | 12.13 | 12.76 | 6.89 | 12.74 | 1.47 | 0.05 | 0.18 |
Accounts Payable Turnover |
0.07 | 0.00 | 1.77 | 6.98 | 38.60 | 14.02 | 9.41 | 1.32 | 0.06 | 0.05 |
Inventory Turnover |
0.00 | — | 7.10 | 37.51 | 17.37 | 7.83 | 77.68 | 39.54 | 0.00 | 0.93 |
Average Days of Payables |
5,270.24 | 0.00 | 325.57 | 47.60 | 8.21 | 33.85 | 40.74 | 406.14 | 8,101.27 | 5,262.78 |
Days of Inventory on Hand |
0.00 | — | 65.03 | 8.08 | 40.22 | 4.00 | 5.05 | 0.28 | 0.00 | 778.13 |
Average Receivables |
0.33 | 0.31 | 0.38 | 0.61 | 1.34 | 1.44 | 0.80 | 0.93 | 2.69 | 2.44 |
Average Payables |
0.23 | 0.17 | 0.25 | 0.37 | 0.30 | 0.37 | 0.50 | 1.00 | 2.18 | 2.17 |
Average Inventory |
— | — | 0.06 | 0.07 | 0.66 | 0.66 | 0.06 | 0.03 | — | 0.11 |
Average Assets |
1.18 | 0.48 | 1.42 | 3.90 | 7.68 | 7.78 | 4.74 | 8.12 | 58.69 | 94.52 |
Average Common Equity |
(0.44) | (0.73) | 0.27 | 2.49 | 6.41 | 6.22 | 2.06 | 0.44 | 39.81 | 74.60 |
Columns are period end dates · fundamentals updated 2 Nov 2026